The duration of dual antiplatelet therapy in patients with coronary atherosclerosis after stent implantation

Authors

  • A. B. Sumarokov Russian Cardiology Research Complex

Keywords:

CHD, dual antiplatelettherapy (DAPT), prognosis, Stentimplantation,, ongevity of DAPT

Abstract

Optimal longevity of dual antiplatelet therapy is uncertain. After implantation of drug-eluting stent 6-12 months dual antiplatelet therapy (DAPT) is needed. After this, some of patients have risk of thrombotic complications, very late stent thrombosis. From other hand, there is real risk of haemorrhagia. This review discuss results of long-term DAPT in clinical trials and meta-analyses on this theme.

Downloads

Download data is not yet available.

Downloads

Published

2016-06-25

How to Cite

Sumarokov A. B. The duration of dual antiplatelet therapy in patients with coronary atherosclerosis after stent implantation // The Journal of Atherosclerosis and Dyslipidemias. 2016. VOL. № 2 (23). PP. 18–32.

Issue

No. 2 (23) (2016)

Section

Review

Most read articles by the same author(s)